Species;Gender;TrainingStatus;VO2max;Tissue;FiberType;ExType;ExDuration(sec);ExDuration(min);ExIntencity(%VO2max);CoFactor;Target;TargetOriginal;ImpactType;FoldChange; ActivationTime(min)  ;" TimePoint
(ours)  ";[Target0];[Target1];MeasureUnit;MethodOfMeasurement;Commentary;Ref;Reference
Homo sapiens;;active;;vastus lateralis;I;All-Out;8;0.133333333;200;;PCr/Cr;PCr/Cr;0;0.636363636363636;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;8;0.133333333;200;;PCr/Cr;PCr/Cr;0;0.578947368421053;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;IIb;All-Out;8;0.133333333;200;;PCr/Cr;PCr/Cr;0;0.5;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;I;All-Out;14;0.233333333;200;;PCr/Cr;PCr/Cr;0;0.454545454545455;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;14;0.233333333;200;;PCr/Cr;PCr/Cr;0;0.315789473684211;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;IIb;All-Out;14;0.233333333;200;;PCr/Cr;PCr/Cr;0;0.3;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;I;All-Out;20;0.3;200;;PCr/Cr;PCr/Cr;0;0.318181818181818;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;20;0.3;200;;PCr/Cr;PCr/Cr;0;0.210526315789474;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;IIb;All-Out;20;0.3;200;;PCr/Cr;PCr/Cr;0;0.2;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;four. seven and/or 10 MVC (1 s on. 1 s off) of the m. quadriceps (60grad-flexion angle);Beltman 2004;J. G. M. Beltman. A. J. Sargeant. H. Haan. W. van Mechelen3 and A. de Haan. Changes in PCr/Cr ratio in single characterized muscle fibre fragments after only a few maximal voluntary contractions in humans. Acta Physiol Scand 2004. 180. 187?193.
Homo sapiens;;active;;vastus lateralis;I;All-Out;10;0.166666667;300;;PCr;Cr;0;0.54;;;43495;66.6;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;10;0.166666667;300;;PCr;Cr;0;0.47;;;37.7;78.2;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIax;All-Out;10;0.166666667;300;;PCr;Cr;0;0.38;;;38.7;78.6;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIx;All-Out;10;0.166666666666667;300;;PCr;Cr;0;0.41;;;36.4;94.9;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;I;All-Out;10;0.166666667;300;;PCr;PCr;0;0.54;;;69.5;37.5;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;10;0.166666667;300;;PCr;PCr;0;0.47;;;73.6;34.3;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIax;All-Out;10;0.166666667;300;;PCr;PCr;0;0.38;;;73.3;43582;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIx;All-Out;10;0.166666666666667;300;;PCr;PCr;0;0.41;;;69.6;43552;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;I;All-Out;10;0.166666666666667;300;;PCr/Cr;PCr/Cr;0;0.243858966880549;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;10;0.166666666666667;300;;PCr/Cr;PCr/Cr;0;0.224673009562994;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIax;All-Out;10;0.166666666666667;300;;PCr/Cr;PCr/Cr;0;0.184049654770211;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIx;All-Out;10;0.166666666666667;300;;PCr/Cr;PCr/Cr;0;0.155959691387183;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;I;All-Out;10;0.166666666666667;300;;ATP;ATP;1;1.042194092827;;;43669;43670;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;10;0.166666666666667;300;;ATP;ATP;0;0.596837944664032;;;43549;43480;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIax;All-Out;10;0.166666666666667;300;;ATP;ATP;0;0.327935222672065;;;43670;43473;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIx;All-Out;10;0.166666666666667;300;;ATP;ATP;0;0.292;;;25;43531;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;I;All-Out;10;0.166666666666667;300;;IMP;IMP;1;1;;;0;0;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;10;0.166666666666667;300;;IMP;IMP;1;10.4;;;0;43565;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIax;All-Out;10;0.166666666666667;300;;IMP;IMP;1;43481;;;0;43481;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIx;All-Out;10;0.166666666666667;300;;IMP;IMP;1;43663;;;0;43663;mmol/(kg dry mass);reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;I;All-Out;10;0.166666666666667;300;;IMP/ATP;IMP/ATP;1;1;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIa;All-Out;10;0.166666666666667;300;;IMP/ATP;IMP/ATP;1;17.2185430463576;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIax;All-Out;10;0.166666666666667;300;;IMP/ATP;IMP/ATP;1;49.6913580246912;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;;active;;vastus lateralis;IIx;All-Out;10;0.166666666666667;300;;IMP/ATP;IMP/ATP;1;60.6164383561645;;;;;;reverse-phase high-performance liquid chromatography (HPLC) with ultra-violet photometric detection;IMP where n.a. was assigned to 1 for FoldChange calculation. 10 s maximal effort at 120 crank revolutions per minute on an isokinetic cycle ergometer;Karatzaferi 2001;C. Karatzaferi. A. de Haan. W. van Mechelen and A. J. Sargeant. Metabolic changes in single human muscle fibres during brief maximal exercise. Experimental Physiology (2001) 86.3. 411?415.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;5400;90;65;;PGC-1a;PGC-1a;1;1;;;;;a.u.;Western blot analysis;cycling for 90 min at an intensity that elicited ~65% VO2peak;Little 2010;Little JP. Safdar A. Cermak N. Tarnopolsky MA. Gibala MJ. Acute endurance exercise increases the nuclear abundance of PGC-1a in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 298: R912?R917. 2010.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;5400;90;65;;PGC-1a nuclear;PGC-1a nuclear;1;19725;;;;;a.u.;Western blot analysis;cycling for 90 min at an intensity that elicited ~65% VO2peak;Little 2010;Little JP. Safdar A. Cermak N. Tarnopolsky MA. Gibala MJ. Acute endurance exercise increases the nuclear abundance of PGC-1a in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 298: R912?R917. 2010.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;5400;90;65;;ACCp-;ACCp-;1;5;;;;;a.u.;Western blot analysis;cycling for 90 min at an intensity that elicited ~65% VO2peak;Little 2010;Little JP. Safdar A. Cermak N. Tarnopolsky MA. Gibala MJ. Acute endurance exercise increases the nuclear abundance of PGC-1a in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 298: R912?R917. 2010.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;5400;90;65;;AMPKp-;AMPKp-;1;2;;;0.42;0.83;a.u.;Western blot analysis;cycling for 90 min at an intensity that elicited ~65% VO2peak;Little 2010;Little JP. Safdar A. Cermak N. Tarnopolsky MA. Gibala MJ. Acute endurance exercise increases the nuclear abundance of PGC-1a in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 298: R912?R917. 2010.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;5400;90;65;;muscle glycogen;muscle glycogen;0;0.48951048951049;;;572;280;mmol/(kg dry weight);fluorometric enzymatic assay;cycling for 90 min at an intensity that elicited ~65% VO2peak;Little 2010;Little JP. Safdar A. Cermak N. Tarnopolsky MA. Gibala MJ. Acute endurance exercise increases the nuclear abundance of PGC-1a in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 298: R912?R917. 2010.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;5400;90;65;;p38 MAPKp-;p38 MAPKp-;1;43650;;;;;a.u.;Western blot analysis;cycling for 90 min at an intensity that elicited ~65% VO2peak;Little 2010;Little JP. Safdar A. Cermak N. Tarnopolsky MA. Gibala MJ. Acute endurance exercise increases the nuclear abundance of PGC-1a in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 298: R912?R917. 2010.
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;PGC-1a mRNA;PGC-1a mRNA;1;43592;;3;;;a.u.;Real-time RT-PCR;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;CS mRNA;CS mRNA;1;28126;;3;;;a.u.;Real-time RT-PCR;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;COX II mRNA;COX II mRNA;1;30317;;3;;;a.u.;Real-time RT-PCR;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;COX IV mRNA;COX IV mRNA;1;27760;;3;;;a.u.;Real-time RT-PCR;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;PGC-1a nuclear;PGC-1a nuclear;1;24108;;3;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;PGC-1a;PGC-1a;1;20821;;24;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;p38 MAPKp-;p38 MAPKp-;1;43132;;0;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;ACCp-;ACCp-;1;28522;;0;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;CS;CS;1;43525;;24;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;COX II;COX II;1;47119;;24;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;COX IV;COX IV;1;43525;;24;;;a.u.;Western blot analysis;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;CS activity;CS activity;1;41640;;24;4;43620;mmol*kg of protein-1*h-1 wet weight;spectrophotometer;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;active;45;vastus lateralis;;HIT;120;2;200;;COX activity;COX activity;1;43466;;24;43678;43498;mmol*kg of protein-1*h-1 wet weight;spectrophotometer;4 x 30-s all-out cycling separated by 4 min of rest;Little 2011;Little JP. Safdar A. Bishop D. Tarnopolsky MA. Gibala MJ. An acute bout of high-intensity interval training increases the nuclear abundance of PGC-1a and activates mitochondrial biogenesis in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 300: R1303?R1310. 2011
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;adrenaline;adrenaline;1;5;;;0.16;0.8;nmol l?1;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;noradrenaline;noradrenaline;1;2;;;1;2;nmol l?1;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;cAMP;cAMP;1;1.36842105263158;;;43680;43501;?mol kg (d.w)?1;commercial kit (cyclic AMP (H3) assay;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;muscle glycogen;Glycogen;0;0.736641221374046;;;524;386;mmol (kg d.w.)?1;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;La blood;blood lactate;1;43679;;;1;43679;mM;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;Cr;Cr;1;1.18965517241379;;;58;69;mmol (kg d.w.)?1;measured fluormetrically;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;PCr;PCr;0;0.828125;;;64;53;mmol (kg d.w.)?1;measured fluormetrically;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;ATP;AMP;1;0.980769230769231;;;26;43610;mmol (kg d.w.)?1;reverse-phase HPLC;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;ADP;ADP;1;1.03125;;;43499;43527;mmol (kg d.w.)?1;reverse-phase HPLC;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;AMP;AMP;1;43556;;;0.25;0.26;mmol (kg d.w.)?1;reverse-phase HPLC;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;AMP/ATP;AMP/ATP;1;0.946428571428571;;;43800;43617;;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;AMPKa1 activity;AMPKa1 activity;1;1.47368421052632;;;0.95;43556;pmol min?1 mg?1;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;AMPKa2 activity;AMPKa2 activity;1;45717;;;0.2;0.65;pmol min?1 mg?1;;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;AMPKp-;AMPKp-;1;2;;;;;a.u.;Western blotting;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;1;trained;53;vastus lateralis;;Endurance;2400;40;80;;ACCp-;ACCp-;1;6;;;;;a.u.;Western blotting;one-legged knee extensor exercise for 40 min with an intensity of 80% PWL (50? 2W);Kristensen 2007;Jonas M?ller Kristensen. Anders Bo Johnsen. Jesper B. Birk. Jakob Nis Nielsen. Bente Rona Jensen. Ylva Hellsten. Erik A. Richter and J?rgen F. P.Wojtaszewski. Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585.3 (2007) pp 897?909 897.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;muscle glycogen;Glycogen;1;0.778;;;500;389;mmol/kg dry muscle;enzymatic fluorometric method;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;La muscle;La muscle;1;21.4186046511628;;;43528;92.1;mmol/kg dry muscle;;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;IMP;IMP;1;315;;;0.02;43530;mmol/kg dry muscle;HPLC;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;PCr;PCr;0;0.408163265306122;;;85;34.7;mmol/kg dry muscle;enzymatic fluorometric techniques;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;ATP;ATP;0;0.72463768115942;;;43487;16;mmol/kg dry muscle;HPLC;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;ADPfree;ADPfree;1;1.43023255813953;;;86;123;?mol/kg dry muscle;HPLC;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;AMPfree;AMPfree;1;3;;;0.37;43770;?mol/kg dry muscle;HPLC;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;AMPfree/ATP;AMPfree/ATP;1;3.1875;;;0.16;0.51;;;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;AMPKa1 activity;AMPKa1 activity;1;3;;;;;a.u.;;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;AMPKa2 activity;AMPKa2 activity;1;43498;;;;;a.u.;;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;ACCp-;ACCp-;1;43593;;;;;a.u.;;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;;sedentary;40;vastus lateralis;;All-Out;30;0.5;300;;nNOSmp-;nNOSmp-;1;43590;;;;;a.u.;;30-s bicycle sprint exercise;Chen 2000;Chen. Zhi-Ping. Glenn K. McConell. Belinda J. Michell. Rodney J. Snow. Benedict J. Canny. and Bruce E. Kemp. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202?E1206. 2000.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;epinephrine;plasma epinephrine;1;70;;;0.1;7;nmol l?1;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;epinephrine;plasma epinephrine;1;10;;;0.1;1;nmol l?1;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;norepinephrine;Plasma norepinephrine;1;9;;;3;27;nmol l?1;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;norepinephrine;Plasma norepinephrine;1;9;;;3;27;nmol l?1;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;La muscle;muscle lactate;1;3.30434782608696;;;43620;43511;mmol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;La muscle;muscle lactate;1;1.7843137254902;;;43470;43474;mmol/kg dm;`;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;ATP;ATP;1;0.952205882352941;;;43523;43733;mmol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;ATP;ATP;1;0.974264705882353;;;43523;43611;mmol/kg dm;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;ADPfree;ADPfree;1;4.04347826086957;;;138;558;?mol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;ADPfree;ADPfree;1;20515;;;125;445;?mol/kg dm;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;AMPfree;AMPfree;1;17.6666666666667;;;0.9;43723;?mol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;AMPfree;AMPfree;1;27699;;;0.8;43564;?mol/kg dm;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;AMPfree/ATP;AMPfree/ATP;1;21;;;0.03;0.63;;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;AMPfree/ATP;AMPfree/ATP;1;27638;;;0.04;0.39;;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;PCr;PCr;0;0.482005141388175;;;77.8;37.5;mmol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;PCr;PCr;0;0.557124518613607;;;77.9;43.4;mmol/kg dm;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;Cr;Cr;1;2.04207920792079;;;40.4;82.5;mmol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;Cr;Cr;1;2.0106100795756;;;37.7;75.8;mmol/kg dm;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;PCr/Cr;;0;0.236036457116149;;;1.92574257425743;0.454545454545455;;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;PCr/Cr;;0;0.277092273769565;;;2.06631299734748;0.572559366754617;;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;muscle glycogen;Muscle glycogen;0;0.2;;;500;100;mmol/kg dm;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;muscle glycogen;Muscle glycogen;0;0.338461538461538;;;520;176;mmol/kg dm;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;AMPKa1 activity;;1;45689;;;2;43589;pmol min?1 mg?1;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;AMPKa1 activity;;1;27395;;;2;43588;pmol min?1 mg?1;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;AMPKa2 activity;;1;3.14285714285714;;;43588;11;pmol min?1 mg?1;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;AMPKa2 activity;;1;3.42857142857143;;;43588;12;pmol min?1 mg?1;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;AMPKp-;AMPK a2 Thr172 phosphorylation;1;5.71428571428571;;;0.035;0.2;a.u.;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;AMPKp-;AMPK a2 Thr172 phosphorylation;1;43680;;;0.05;0.19;a.u.;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;;ACCp-;ACCb Ser222 phosphorylation;1;16.6666666666667;;;0.15;43587;a.u.;;;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;active;48.5;vastus lateralis;;Endurance;7200;120;65;CHO supplementation;ACCp-;ACCb Ser222 phosphorylation;1;15;;;0.2;3;a.u.;;a bolus of 44.3 mmol/kg of the glucose tracer was administered intravenously immediately before commencement of a 120-min preexercise constant infusion (0.58 mmol/kg-1/min-1). which was continued throughout the exercise bout;Lee-Young 2006;Lee-Young. Robert S.. Matthew J. Palmer. Kelly C. Linden. Kieran LePlastrier. Benedict J. Canny. Mark Hargreaves. Glenn D. Wadley. Bruce E. Kemp. and Glenn K. McConell. Carbohydrate ingestion does not alter skeletal muscle AMPK signaling during exercise in humans. Am J Physiol Endocrinol Metab 291: E566?E573. 2006.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;67;;Plasma lactate;Plasma lactate;1;4.30769230769231;;;43525;43621;mmol/l;;cycling exercise for 60 min at 67 +- 5% VO2 peak;Wilson 2006;Wilson. Chris. Mark Hargreaves. and Kirsten F. Howlett. Exercise does not alter subcellular localization. but increases phosphorylation of insulin-signaling proteins in human skeletal muscle. Am J Physiol Endocrinol Metab 290: E341?E346. 2006.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;67;;IRS-1p-;IRS-1 Tyr612 in the cytosol fraction;1;1.60574412532637;;3;30376;42156;a.u.;Immunoblotting;cycling exercise for 60 min at 67 +- 5% VO2 peak;Wilson 2006;Wilson. Chris. Mark Hargreaves. and Kirsten F. Howlett. Exercise does not alter subcellular localization. but increases phosphorylation of insulin-signaling proteins in human skeletal muscle. Am J Physiol Endocrinol Metab 290: E341?E346. 2006.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;67;;Aktp-;Akt Ser473;1;1.52173913043478;;1;43526;43588;a.u.;Immunoblotting;cycling exercise for 60 min at 67 +- 5% VO2 peak;Wilson 2006;Wilson. Chris. Mark Hargreaves. and Kirsten F. Howlett. Exercise does not alter subcellular localization. but increases phosphorylation of insulin-signaling proteins in human skeletal muscle. Am J Physiol Endocrinol Metab 290: E341?E346. 2006.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;67;;GSK-3p-;GSK-3 Ser9/21;1;43618;;1;43586;43711;a.u.;Immunoblotting;cycling exercise for 60 min at 67 +- 5% VO2 peak;Wilson 2006;Wilson. Chris. Mark Hargreaves. and Kirsten F. Howlett. Exercise does not alter subcellular localization. but increases phosphorylation of insulin-signaling proteins in human skeletal muscle. Am J Physiol Endocrinol Metab 290: E341?E346. 2006.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;AMPKa2 activity;activity of AMPK a2;1;43558;;;1;43558;pmol/min/mg;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;AMPKa1 activity;activity of AMPK a1;1;0.833333333333333;;;43678;43586;pmol/min/mg;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;AMPKp-;AMPK Thr172 phosphorylation;1;43498;;;100;220;a.u.;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;ACCp-;;1;2.90909090909091;;;110;320;a.u.;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;Aktp-;;1;1;;;;;a.u.;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;TBC1D1p-;Ser231and Ser660 phosphorylation. whereas there was only a slight tendency for exercise to increase TBC1D1 Ser700 phosphorylation;1;2;;;;;a.u.;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;AS160p-;AS160 Ser711;1;43678;;;;;a.u.;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;obese;35;vastus lateralis;;Endurance;1800;30;70;;muscle glycogen;Muscle glycogen;1;0.482758620689655;;;58;28;nmol/mg muscle;;30-min on the cycle ergometer at 70% of VO2max;Jessen 2011;Jessen N. An D. Lihn AS. Nygren J. Hirshman MF. Thorell A. Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164?E171. 2011.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;PGC-1a mRNA;PGC-1? mRNA;1;43680;;3;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;PGC-1a mRNA;PGC-1? mRNA;1;43506;;3;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;PDK4 mRNA;PDK4 mRNA;1;43683;;3;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;PDK4 mRNA;PDK4 mRNA;1;43503;;3;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;AMPKp-;AMPK phosphorylation;1;1;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;AMPKp-;AMPK phosphorylation;1;43679;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;ACCp-;ACC? phosphorylation;1;43526;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;ACCp-;ACC? phosphorylation;1;43501;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;p38 MAPKp-;p38 MAPK phosphorylation;1;2;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;p38 MAPKp-;p38 MAPK phosphorylation;1;2;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;ATF-2p-;ATF-2 phosphorylation;1;1;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;ATF-2p-;ATF-2 phosphorylation;1;43557;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;CaMKIIp-;CaMKII phosphorylation;1;1;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;CaMKIIp-;CaMKII phosphorylation;1;30682;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;CREBp-;CREB phosphorylation;1;43678;;3;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;CREBp-;CREB phosphorylation;1;43678;;3;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;HDACIIap-;Phosphorylation of class IIa HDACs;1;1;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;HDACIIap-;Phosphorylation of class IIa HDACs;1;2;;;;;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;4200;70;40;;La plasma ;Plasma lactate;1;0.883928571428571;;;43800;0.99;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;sedentary;40;vastus lateralis;;Endurance;2160;36;80;;La plasma ;Plasma lactate;1;5.92622950819672;;;44562;45108;;;;Egan 2010;Brendan Egan. Brian P. Carson. Pablo M. Garcia-Roves. Alexander V. Chibalin. Fiona M. Sarsfield. Niall Barron. Noel McCaffrey. Niall M. Moyna. Juleen R. Zierath and Donal J. O?Gorman. Exercise intensity-dependent regulation of peroxisome proliferator-activated receptor ? coactivator-1? mRNA abundance is associated with differential activation of upstream signalling kinases in human skeletal muscle. J Physiol 588.10 (2010) pp 1779?1790 1779.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;ERK1/2p-;ERK1/2 MAPK phosphorylation;1;43586;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;ERK1/2p-;ERK1/2 MAPK phosphorylation;1;43618;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;p38 MAPKp-;p38 MAPK phosphorylation;1;43617;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;p38 MAPKp-;p38 MAPK phosphorylation;1;43467;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;MSK1 activity;MSK1 activity;1;43556;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;MSK1 activity;MSK1 activity;1;2;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;H3p-;Nuclear protein histone H3 phosphorylation;1;43678;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;H3p-;Nuclear protein histone H3 phosphorylation;1;43709;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;AMPKa1 activity;;1;1;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;AMPKa1 activity;;1;1;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;AMPKa2 activity;AMPKa2 activity;1;43526;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;AMPKa2 activity;AMPKa2 activity;1;43500;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;AMPKp-;AMPKa phosphorylation;1;43556;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;AMPKp-;AMPKa phosphorylation;1;43498;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;highly trained;67;vastus lateralis;;Endurance;2400;40;86;;ACCp-;ACC phosphorylation;1;43679;;;;;;;highly trained subjects completed eight 5 min bouts of intense cycling at a power output of 334 ? 18 W. This exercise protocol elicited an average relative intensity of 86 ? 2 % of VO2peak.;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1200;20;84;;ACCp-;ACC phosphorylation;1;43709;;;;;;;control subjects complete four 5 min bouts of intense cycling at a power output of 241 ? 11 W. The relative exercise intensity 84 ? 1 % of VO2peak;Yu 2003;Mei Yu. Nigel K. Stepto. Alexander V. Chibalin. Lee G. D. Fryer. Dave Carling. Anna Krook. John A. Hawley and Juleen R. Zierath. Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. J Physiol (2003). 546.2. pp. 327?335.
Homo sapiens;;sedentary;40;vastus lateralis;;Strength;480;8;300;concentric;MKK4 activity;MKK4 activity;1;43678;;;;;;;MKK4 activation did not differ between concentric and eccentric exercise groups;Boppart 1999;Boppart. Marni D.. Doron Aronson. Lindsay Gibson. Ronenn Roubenoff. Leslie W. Abad. Jonathan Bean. Laurie J. Goodyear. and Roger A. Fielding. Eccentric exercise markedly increases c-JunNH2-terminal kinase activity in human skeletal muscle. J. Appl. Physiol. 87(5): 1668? 1673. 1999.
Homo sapiens;;sedentary;40;vastus lateralis;;Strength;480;8;300;eccentric;MKK4 activity;MKK4 activity;1;43678;;;;;;;MKK4 activation did not differ between concentric and eccentric exercise groups;Boppart 1999;Boppart. Marni D.. Doron Aronson. Lindsay Gibson. Ronenn Roubenoff. Leslie W. Abad. Jonathan Bean. Laurie J. Goodyear. and Roger A. Fielding. Eccentric exercise markedly increases c-JunNH2-terminal kinase activity in human skeletal muscle. J. Appl. Physiol. 87(5): 1668? 1673. 1999.
Homo sapiens;;sedentary;40;vastus lateralis;;Strength;480;8;300;concentric;JNK activity;JNK activity;1;43588;;;;;;;MKK4 activation did not differ between concentric and eccentric exercise groups;Boppart 1999;Boppart. Marni D.. Doron Aronson. Lindsay Gibson. Ronenn Roubenoff. Leslie W. Abad. Jonathan Bean. Laurie J. Goodyear. and Roger A. Fielding. Eccentric exercise markedly increases c-JunNH2-terminal kinase activity in human skeletal muscle. J. Appl. Physiol. 87(5): 1668? 1673. 1999.
Homo sapiens;;sedentary;40;vastus lateralis;;Strength;480;8;300;eccentric;JNK activity;JNK activity;1;43600;;;;;;;MKK4 activation did not differ between concentric and eccentric exercise groups;Boppart 1999;Boppart. Marni D.. Doron Aronson. Lindsay Gibson. Ronenn Roubenoff. Leslie W. Abad. Jonathan Bean. Laurie J. Goodyear. and Roger A. Fielding. Eccentric exercise markedly increases c-JunNH2-terminal kinase activity in human skeletal muscle. J. Appl. Physiol. 87(5): 1668? 1673. 1999.
Homo sapiens;;well trained;60;vastus lateralis;;Endurance;12900;215;65;;MKK4p-;MKK4 phosphorylation;1;4;;;;;;;42.2 km marathon (mean race time 3 h 35 min);Boppart 2000;Marni D. Boppart. Sven Asp. Joergen F. P. Wojtaszewski. Roger A. Fielding. Thomas Mohr and Laurie J. Goodyear. Marathon running transiently increases cJun NH?terminal kinase and p38? activities in human skeletal muscle. Journal of Physiology (2000). 526.3. pp. 663?669 663.
Homo sapiens;;well trained;60;vastus lateralis;;Endurance;12900;215;65;;MKK6p-;MKK6 phosphorylation;1;43586;;;;;;;42.2 km marathon (mean race time 3 h 35 min);Boppart 2000;Marni D. Boppart. Sven Asp. Joergen F. P. Wojtaszewski. Roger A. Fielding. Thomas Mohr and Laurie J. Goodyear. Marathon running transiently increases cJun NH?terminal kinase and p38? activities in human skeletal muscle. Journal of Physiology (2000). 526.3. pp. 663?669 663.
Homo sapiens;;well trained;60;vastus lateralis;;Endurance;12900;215;65;;JNK activity;JNK activity;1;7;;;;;;;42.2 km marathon (mean race time 3 h 35 min);Boppart 2000;Marni D. Boppart. Sven Asp. Joergen F. P. Wojtaszewski. Roger A. Fielding. Thomas Mohr and Laurie J. Goodyear. Marathon running transiently increases cJun NH?terminal kinase and p38? activities in human skeletal muscle. Journal of Physiology (2000). 526.3. pp. 663?669 663.
Homo sapiens;;well trained;60;vastus lateralis;;Endurance;12900;215;65;;p38ap-;p38a phosphorylation;1;1;;;;;;;42.2 km marathon (mean race time 3 h 35 min);Boppart 2000;Marni D. Boppart. Sven Asp. Joergen F. P. Wojtaszewski. Roger A. Fielding. Thomas Mohr and Laurie J. Goodyear. Marathon running transiently increases cJun NH?terminal kinase and p38? activities in human skeletal muscle. Journal of Physiology (2000). 526.3. pp. 663?669 663.
Homo sapiens;;well trained;60;vastus lateralis;;Endurance;12900;215;65;;p38yp-;p38y phosphorylation;1;4;;;;;;;42.2 km marathon (mean race time 3 h 35 min);Boppart 2000;Marni D. Boppart. Sven Asp. Joergen F. P. Wojtaszewski. Roger A. Fielding. Thomas Mohr and Laurie J. Goodyear. Marathon running transiently increases cJun NH?terminal kinase and p38? activities in human skeletal muscle. Journal of Physiology (2000). 526.3. pp. 663?669 663.
Homo sapiens;;well trained;60;vastus lateralis;;Endurance;12900;215;65;;p38y activity;p38y phosphorylation;1;43586;;;;;;;42.2 km marathon (mean race time 3 h 35 min);Boppart 2000;Marni D. Boppart. Sven Asp. Joergen F. P. Wojtaszewski. Roger A. Fielding. Thomas Mohr and Laurie J. Goodyear. Marathon running transiently increases cJun NH?terminal kinase and p38? activities in human skeletal muscle. Journal of Physiology (2000). 526.3. pp. 663?669 663.
Homo sapiens;1;well trained;50;vastus lateralis;;Strength;3600;60;400;;ERK1/2p-;ERK 1/2 phosphorylation;1;43525;;;;;;;15 sets of 3 repetitions of a dynamic clean pull at 85% 1RM;Galpin 2011;Andrew J. Galpin. Andrew C. Fry. Loren Z.F. Chiu. Donald B. Thomason. and Brian K. Schilling. High-power resistance exercise induces MAPK phosphorylation in weightlifting trained men. Appl. Physiol. Nutr. Metab. 37: 80?87 (2011) doi:10.1139/H11-131
Homo sapiens;1;well trained;50;vastus lateralis;;Strength;3600;60;400;;p38 MAPKp-;p38 phosphorylation;1;17533;;;;;;;15 sets of 3 repetitions of a dynamic clean pull at 85% 1RM;Galpin 2011;Andrew J. Galpin. Andrew C. Fry. Loren Z.F. Chiu. Donald B. Thomason. and Brian K. Schilling. High-power resistance exercise induces MAPK phosphorylation in weightlifting trained men. Appl. Physiol. Nutr. Metab. 37: 80?87 (2011) doi:10.1139/H11-131
Homo sapiens;1;well trained;50;vastus lateralis;;Strength;3600;60;400;;JNKp-;JNK phosphorylation;1;14977;;;;;;;15 sets of 3 repetitions of a dynamic clean pull at 85% 1RM;Galpin 2011;Andrew J. Galpin. Andrew C. Fry. Loren Z.F. Chiu. Donald B. Thomason. and Brian K. Schilling. High-power resistance exercise induces MAPK phosphorylation in weightlifting trained men. Appl. Physiol. Nutr. Metab. 37: 80?87 (2011) doi:10.1139/H11-131
Homo sapiens;;sedentary;40;vastus lateralis;;Endurance;3600;60;70;;JNK activity;JNK activity;1;43713;;;;;;;60 min of cycle ergometer exercise 70% VO2 max;Aronson 1998;Doron Aronson. Marni D. Boppart. Scott D. Dufresne. Roger A. Fielding. and Laurie J. Goodyear. Exercise Stimulates c-Jun NH2 Kinase Activity and c-Jun Transcriptional Activity in Human Skeletal Muscle. Biochemical And Biophysical Research Communications 251. 106?110 (1998)
Homo sapiens;;sedentary;40;vastus lateralis;;Endurance;3600;60;70;;c-jun mRNA;c-jun mRNA;1;43678;;;;;;;60 min of cycle ergometer exercise 70% VO2 max;Aronson 1998;Doron Aronson. Marni D. Boppart. Scott D. Dufresne. Roger A. Fielding. and Laurie J. Goodyear. Exercise Stimulates c-Jun NH2 Kinase Activity and c-Jun Transcriptional Activity in Human Skeletal Muscle. Biochemical And Biophysical Research Communications 251. 106?110 (1998)
Homo sapiens;;sedentary;53;vastus lateralis;;Endurance;3600;60;70;;MSK1 activity;;1;5;10;;;;;;MSK1 and MSK2 downstream of p42/44 ERK and p38 MAP kinase;Krook 2000;Krook. Anna. Ulrika Widegren. Xin Jian Jiang. Jan Henriksson. Harriet Wallberg-Henriksson. Dario Alessi. and Juleen R. Zierath. Effects of exercise on mitogen- and stress-activated kinase signal transduction in human skeletal muscle. Am J Physiol Regulatory Integrative Comp Physiol 279: R1716?R1721. 2000.
Homo sapiens;;sedentary;53;vastus lateralis;;Endurance;3600;60;70;;MSK2 activity;;1;3;10;;;;;;MSK1 and MSK2 downstream of p42/44 ERK and p38 MAP kinase;Krook 2000;Krook. Anna. Ulrika Widegren. Xin Jian Jiang. Jan Henriksson. Harriet Wallberg-Henriksson. Dario Alessi. and Juleen R. Zierath. Effects of exercise on mitogen- and stress-activated kinase signal transduction in human skeletal muscle. Am J Physiol Regulatory Integrative Comp Physiol 279: R1716?R1721. 2000.
Homo sapiens;;sedentary;53;vastus lateralis;;Endurance;3600;60;70;;MAPKAPK1;;1;25;10;;;;;;p90 ribosomal S6 kinase (p90rsk. also known as MAPKAPK1) downstream targets of p42/44 ERK;Krook 2000;Krook. Anna. Ulrika Widegren. Xin Jian Jiang. Jan Henriksson. Harriet Wallberg-Henriksson. Dario Alessi. and Juleen R. Zierath. Effects of exercise on mitogen- and stress-activated kinase signal transduction in human skeletal muscle. Am J Physiol Regulatory Integrative Comp Physiol 279: R1716?R1721. 2000.
Homo sapiens;;sedentary;53;vastus lateralis;;Endurance;3600;60;70;;MAPKAPK2;;1;3;10;;;;;;downstream targets of p38 MAP kinase;Krook 2000;Krook. Anna. Ulrika Widegren. Xin Jian Jiang. Jan Henriksson. Harriet Wallberg-Henriksson. Dario Alessi. and Juleen R. Zierath. Effects of exercise on mitogen- and stress-activated kinase signal transduction in human skeletal muscle. Am J Physiol Regulatory Integrative Comp Physiol 279: R1716?R1721. 2000.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;1800;30;40;;MEK1/2p-;;1;43587;30;;;;;;one-leg cycle ergometer 30 min at 40% and 75% of one-leg VO2max;Widegren 2000;U. Widegren. C. Wretman. A. Lionikas. G. Hedin. J. Henriksson. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pfl?gers Arch - Eur J Physiol (2000) 441:317?322.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;1800;30;75;;MEK1/2p-;;1;43681;30;;;;;;one-leg cycle ergometer 30 min at 40% and 75% of one-leg VO2max;Widegren 2000;U. Widegren. C. Wretman. A. Lionikas. G. Hedin. J. Henriksson. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pfl?gers Arch - Eur J Physiol (2000) 441:317?322.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;1800;30;40;;ERK1/2p-;;1;43596;30;;;;;;one-leg cycle ergometer 30 min at 40% and 75% of one-leg VO2max;Widegren 2000;U. Widegren. C. Wretman. A. Lionikas. G. Hedin. J. Henriksson. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pfl?gers Arch - Eur J Physiol (2000) 441:317?322.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;1800;30;75;;ERK1/2p-;;1;39.7;30;;;;;;one-leg cycle ergometer 30 min at 40% and 75% of one-leg VO2max;Widegren 2000;U. Widegren. C. Wretman. A. Lionikas. G. Hedin. J. Henriksson. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pfl?gers Arch - Eur J Physiol (2000) 441:317?322.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;1800;30;40;;CREBp-;;1;43557;30;;;;;;"had no significant effect on CREB phosphorylation (basal: 28.6?9.8; low intensity: 70.5?43.6; high intensity: 65.9?39.0)";Widegren 2000;U. Widegren. C. Wretman. A. Lionikas. G. Hedin. J. Henriksson. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pfl?gers Arch - Eur J Physiol (2000) 441:317?322.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;1800;30;75;;CREBp-;;1;43526;30;;;;;;"had no significant effect on CREB phosphorylation (basal: 28.6?9.8; low intensity: 70.5?43.6; high intensity: 65.9?39.0)";Widegren 2000;U. Widegren. C. Wretman. A. Lionikas. G. Hedin. J. Henriksson. Influence of exercise intensity on ERK/MAP kinase signalling in human skeletal muscle. Pfl?gers Arch - Eur J Physiol (2000) 441:317?322.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;ERK1/2p-;;1;43684;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;p38 MAPKp-;;1;43559;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;MSK1 activity;;1;43557;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;MSK2 activity;;1;43497;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;MAPKAPK1 activity;;1;43679;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;MAPKAPK2 activity;;1;43468;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;trained;55;vastus lateralis;;Endurance;14400;240;50;;MEF2 DNA binding;;1;43647;;;;;;;42.2 km marathon;Yu 2001;Mei Yu. Eva Blomstrand. Alexander V. Chibalin. Anna Krook and Juleen R. Zierath. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. Journal of Physiology (2001). 536.1. pp.273?282.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;AMPKp-;;1;43468;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;AMPKp-;;1;43497;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;ACCp-;ACC? phosphorylation;1;43557;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;ACCp-;ACC? phosphorylation;1;43648;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;CaMKIIp-;CaMKII phosphorylation;1;11689;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;CaMKIIp-;CaMKII phosphorylation;1;11689;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;Aktp-;Thr308-Akt phosphorylation;1;43557;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;Aktp-;Thr308-Akt phosphorylation;1;43557;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;AS160p-;Thr642-AS160 phosphorylation;1;17168;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;AS160p-;Thr642-AS160 phosphorylation;1;17168;;30;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;SIRT1;SIRT1 protein levels;1;43525;;0;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;SIRT1;SIRT1 protein levels;0;0.5;;0;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. Muscle biopsies were obtained before and immediately after 30 and 120 min postsprint.;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;ATP;ATP. mmol/kg;0;0.49;;0;36251;16834;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;ATP;ATP. mmol/kg;0;0.65;;0;28581;43468;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;AMP/ATP;AMP/ATP. mmol/mol;1;20.6666666666667;;0;43592;155;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;AMP/ATP;AMP/ATP. mmol/mol;1;32.2777777777778;;0;43560;174.3;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;PCr;Phosphocreatine. mmol/kg;0;0.33;;0;43481;12540;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;PCr;Phosphocreatine. mmol/kg;0;0.35;;0;16.56;30437;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;Cr;Creatine. mmol/kg;1;1.8748984565394;;0;11658;43700;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;Cr;Creatine. mmol/kg;1;1.90632911392405;;0;31352;22.59;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;PCr/Cr;;0;0.176903990441026;;0;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;PCr/Cr;;0;0.184675949984282;;0;;;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;Pyr muscle;Pyruvate. mmol/kg;1;2.77777777777778;;0;0.09;0.25;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;Pyr muscle;Pyruvate. mmol/kg;1;1.64285714285714;;0;0.14;0.23;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;normoxia;La muscle;Lactate. mmol/kg;1;14.48;;0;43587;36.2;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;sedentary;50;vastus lateralis;;All-Out;30;0.5;300;hypoxia;La muscle;Lactate. mmol/kg;1;24.1818181818182;;0;43498;53.2;;;30-s sprint (Wingate test) in normoxia and in severe acute hypoxia. ;Morales-Alamo 2012; Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso MR. Guerrero M. Guerra B. Dorado C. Calbet JA. Increased oxidative stress and anaerobic energy release. but blunted Thr172-AMPKa phosphorylation. in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol 113: 917?928. 2012.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;epinephrine;Plasma epinephrine nmol/L;1;6.83333333333333;;0;0.3;43587;;;Typical rest  plasma epinephrine values was taken from other source;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;epinephrine;Plasma epinephrine nmol/L;1;13.1666666666667;;0;0.3;34759;;;Typical rest  plasma epinephrine values was taken from other source;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;muscle glycogen;Glycogen (mmol/kg dm);0;0.284615384615385;;0;390;111;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;muscle glycogen;Glycogen (mmol/kg dm);0;0.113333333333333;;0;150;17;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;AMP;Free AMP (?mol/kg dm);1;17.875;;0;0.16;31444;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMP;Free AMP (?mol/kg dm);1;44.2;;0;0.1;15432;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;ATP;ATP (mmol/kg dm);1;1.00840336134454;;0;43700;24;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;ATP;ATP (mmol/kg dm);0;0.962962962962963;;0;43548;43578;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;AMP/ATP;;1;17.7260416666667;;0;0.00672268907563025;0.119166666666667;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMP/ATP;;0;45.9;;0;0.00411522633744856;0.188888888888889;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;PCr;PCr (mmol/kg dm);1;1.00840336134454;;0;43700;24;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;PCr;PCr (mmol/kg dm);0;0.962962962962963;;0;43548;43578;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;;AMP/ATP;;1;17.7260416666667;;0;0.00672268907563025;0.119166666666667;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;1;active;49;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMP/ATP;;0;45.9;;0;0.00411522633744856;0.188888888888889;;;;Steinberg 2006;Gregory R. Steinberg. Matthew J. Watt. Sean L. McGee. Stanley Chan. Mark Hargreaves. Mark A. Febbraio. David Stapleton. and Bruce E. Kemp. Reduced glycogen availability is associated with increased AMPK?2 activity. nuclear AMPK?2 protein abundance. and GLUT4 mRNA expression in contracting human skeletal muscle. Appl. Physiol. Nutr. Metab. 31: 302?312 (2006) doi:10.1139/H06-003.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;AMPfree/ATP;FreeAMP/ATP;1;27061;;0;0.057;0.156;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;AMPfree/ATP;FreeAMP/ATP;1;43558;;0;0.057;0.173;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;PCr;;0;0.761428571428571;;0;70;53.3;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;PCr;;0;0.745714285714286;;0;70;52.2;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;Cr;;1;1.31931166347992;;0;52.3;69;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;Cr;;1;1.34034416826004;;0;52.3;70.1;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;ATP;;0;0.975;;0;24;43578;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;ATP;;0;0.95;;0;24;43699;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;La muscle;;1;2.70731707317073;;0;43469;43476;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;La muscle;;1;2.31707317073171;;0;43469;43594;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;muscle glycogen;;0;0.946449359720605;;0;429.5;406.5;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;muscle glycogen;;0;0.786961583236321;;0;429.5;338;;;;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;AMPKa2 activity;;1;2;;0;;;;;ACCb phosphorylation;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;AMPKa2 activity;;1;3;;0;;;;;ACCb phosphorylation;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;ACCp-;;1;18;;0;;;;;nNOS phosphorylation;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;ACCp-;;1;36;;0;;;;;nNOS phosphorylation;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;300;5;63;;nNOSp-;;1;43498;;0;;;;;nNOS phosphorylation;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;36;vastus lateralis;;Endurance;1800;30;63;;nNOSp-;;1;43467;;0;;;;;nNOS phosphorylation;Stephens 2002;Stephens. T. J.. Z.-P. Chen. B. J. Canny. B. J. Michell.  B. E. Kemp. and G. K. McConell. Progressive increase in human skeletal muscle AMPKa2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688?E694. 2002.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;3600;60;70;;RSK activity;;1;43467;;0;;;;;;Aronson 1997b;Doron Aronson. Mariona A. Violan. Scott D. Dufresne. David Zangen. Roger A. Fielding. and Laurie J. Goodyear. Exercise Stimulates the Mitogen-activated Protein Kinase Pathway in Human Skeletal Muscle. J. Clin. Invest. 1997. 99:1251?1257.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;3600;60;70;;MAPKp-;;1;14;;0;;;;;4-24 FoldChange range;Aronson 1997b;Doron Aronson. Mariona A. Violan. Scott D. Dufresne. David Zangen. Roger A. Fielding. and Laurie J. Goodyear. Exercise Stimulates the Mitogen-activated Protein Kinase Pathway in Human Skeletal Muscle. J. Clin. Invest. 1997. 99:1251?1257.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;3600;60;70;;MEK1 activity;;1;43527;;0;;;;;;Aronson 1997b;Doron Aronson. Mariona A. Violan. Scott D. Dufresne. David Zangen. Roger A. Fielding. and Laurie J. Goodyear. Exercise Stimulates the Mitogen-activated Protein Kinase Pathway in Human Skeletal Muscle. J. Clin. Invest. 1997. 99:1251?1257.
Homo sapiens;;sedentary;46;vastus lateralis;;Endurance;3600;60;70;;Raf-1 activity;;1;43709;;0;;;;;;Aronson 1997b;Doron Aronson. Mariona A. Violan. Scott D. Dufresne. David Zangen. Roger A. Fielding. and Laurie J. Goodyear. Exercise Stimulates the Mitogen-activated Protein Kinase Pathway in Human Skeletal Muscle. J. Clin. Invest. 1997. 99:1251?1257.
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;70;;AMPKa2 activity;;1;2;;0;;;;;20 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;3600;60;70;;AMPKa2 activity;;1;43587;;0;;;;;60 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;50;;AMPKa2 activity;;1;1;;0;;;;;20 min cycle ergometer 50%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;70;;AMPKa1 activity;;0;0.81;;0;;;;;20 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;3600;60;70;;AMPKa1 activity;;0;1;;0;;;;;60 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;50;;AMPKa1 activity;;0;0.81;;0;;;;;20 min cycle ergometer 50%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;70;;La plasma ;;1;4.57692307692308;;0;0.78;20880;;;20 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;3600;60;70;;La plasma ;;1;3.24358974358974;;0;0.78;19391;;;60 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;50;;La plasma ;;1;1.94871794871795;;0;0.78;18994;;;20 min cycle ergometer 50%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;70;;muscle glycogen;;0;0.65;;0;90;58.5;;;20 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;3600;60;70;;muscle glycogen;;0;0.5;;0;90;45;;;60 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;50;;muscle glycogen;;0;0.866666666666667;;0;90;78;;;20 min cycle ergometer 50%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;70;;PCr;;0;0.3;;0;17;43470;;;20 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;3600;60;70;;PCr;;0;0.558823529411765;;0;17;43594;;;60 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;50;;PCr;;0;1;;0;17;17;;;20 min cycle ergometer 50%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;70;;ATP;;0;0.833333333333333;;0;12;10;;;20 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;3600;60;70;;ATP;;0;0.875;;0;12;43595;;;60 min cycle ergometer 70%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;;sedentary;43;vastus lateralis;;Endurance;1200;20;50;;ATP;;0;1;;0;12;12;;;20 min cycle ergometer 50%  of VO2max ;Fujii 2000;Nobuharu Fujii. Tatsuya Hayashi. Michael F. Hirshman. Jeremy T. Smith. Susan A. Habinowski. Lennart Kaijser. James Mu. Olle Ljungqvist. Morris J. Birnbaum. Lee A. Witters. Anders Thorel. and Laurie J. Goodyear. Exercise Induces Isoform-Specific Increase in 5'AMP-Activated Protein Kinase Activity in Human Skeletal Muscle. Biochemical and Biophysical Research Communications 273. 1150?1155 (2000)
Homo sapiens;1;active;48.4;vastus lateralis;;Endurance;6900;115;65;Low glycogen;Blood glucose;;0;0.691609977324263;;0;15067;43588;;;;Mathai 2008;Mathai AS. Bonen A. Benton CR. Robinson DL. Graham TE. Rapid exercise-induced changes in PGC-1a mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098?1105. 2008.
Homo sapiens;1;active;48.4;vastus lateralis;;Endurance;6900;115;65;High glycogen;Blood glucose;;0;0.850785340314136;;0;30011;45717;;;;Mathai 2008;Mathai AS. Bonen A. Benton CR. Robinson DL. Graham TE. Rapid exercise-induced changes in PGC-1a mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098?1105. 2008.
Homo sapiens;1;active;48.4;vastus lateralis;;Endurance;6900;115;65;Low glycogen;PGC-1a mRNA;;1;7;;2;;;;;;Mathai 2008;Mathai AS. Bonen A. Benton CR. Robinson DL. Graham TE. Rapid exercise-induced changes in PGC-1a mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098?1105. 2008.
Homo sapiens;1;active;48.4;vastus lateralis;;Endurance;6900;115;65;High glycogen;PGC-1a mRNA;;1;7;;2;;;;;;Mathai 2008;Mathai AS. Bonen A. Benton CR. Robinson DL. Graham TE. Rapid exercise-induced changes in PGC-1a mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098?1105. 2008.
Homo sapiens;1;active;48.4;vastus lateralis;;Endurance;6900;115;65;Low glycogen;PGC-1a;;1;43497;;0;;;;;;Mathai 2008;Mathai AS. Bonen A. Benton CR. Robinson DL. Graham TE. Rapid exercise-induced changes in PGC-1a mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098?1105. 2008.
Homo sapiens;1;active;48.4;vastus lateralis;;Endurance;6900;115;65;High glycogen;PGC-1a;;1;43497;;0;;;;;;Mathai 2008;Mathai AS. Bonen A. Benton CR. Robinson DL. Graham TE. Rapid exercise-induced changes in PGC-1a mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098?1105. 2008.
Homo sapiens;1;active;49.7;vastus lateralis;;Endurance;600;10;72;;AMPKa2 nuclear;;1;1;;0;;;;;;McGee 2003;Sean L. McGee. Kirsten F. Howlett. Rebecca L. Starkie. David Cameron-Smith. Bruce E. Kemp. and Mark Hargreaves. Exercise Increases Nuclear AMPKa2 in Human Skeletal Muscle. Diabetes 52:926?928. 2003.
Homo sapiens;1;active;49.7;vastus lateralis;;Endurance;3600;60;72;;AMPKa2 nuclear;;1;43709;;0;;;;;;McGee 2003;Sean L. McGee. Kirsten F. Howlett. Rebecca L. Starkie. David Cameron-Smith. Bruce E. Kemp. and Mark Hargreaves. Exercise Increases Nuclear AMPKa2 in Human Skeletal Muscle. Diabetes 52:926?928. 2003.
Homo sapiens;1;active;49.7;vastus lateralis;;Endurance;600;10;72;;AMPKa2;;1;43466;;0;;;;;;McGee 2003;Sean L. McGee. Kirsten F. Howlett. Rebecca L. Starkie. David Cameron-Smith. Bruce E. Kemp. and Mark Hargreaves. Exercise Increases Nuclear AMPKa2 in Human Skeletal Muscle. Diabetes 52:926?928. 2003.
Homo sapiens;1;active;49.7;vastus lateralis;;Endurance;3600;60;72;;AMPKa2;;1;0.9;;0;;;;;;McGee 2003;Sean L. McGee. Kirsten F. Howlett. Rebecca L. Starkie. David Cameron-Smith. Bruce E. Kemp. and Mark Hargreaves. Exercise Increases Nuclear AMPKa2 in Human Skeletal Muscle. Diabetes 52:926?928. 2003.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;GLUT4 mRNA;;1;43467;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;HDAC5 nuclear;;0;0.46;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;HDAC5assMEF-2;HDAC5 association with MEF-2;0;0.74;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;NFATc nuclear;Nuclear NFAT;1;1;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;PGC-1aassMEF-2;PGC-1 association with MEF-2;1;43649;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;PGC-1a nuclear;;1;1;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;p38 MAPKp-;;1;43681;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;p38 MAPKp- nuclear;;1;43678;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;p38 MAPKassMEF-2;Association of p38 protein with MEF-2;1;43648;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;p38 MAPKp-assMEF-2;association of phosphorylated p38 with MEF-2;1;43678;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;74;;MEF-2p-;MEF-2 threonine-proline phosphorylation;1;43648;;0;;;;;cycling for 60 min at 74% of VO2peak;McGee 2004;Sean L. McGee and Mark Hargreaves. Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle. Diabetes 53:1208?1214. 2004.
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;75;;GEF DNA binding;GEF DNA-binding activity;1;43586;;0;;;;;cycling for 60 min at 75% of VO2peak;McGee 2005;"Sean L. McGee. David Sparling. Ann-Louise Olson. and Mark Hargreaves. Exercise increases MEF2- and GEF DNA-binding activities in human skeletal muscle. FASEB J. 2006 Feb;20(2):348-9."
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;75;;MEF2A nuclear;nuclear abundance of MEF2A;1;2;;0;;;;;cycling for 60 min at 75% of VO2peak;McGee 2005;"Sean L. McGee. David Sparling. Ann-Louise Olson. and Mark Hargreaves. Exercise increases MEF2- and GEF DNA-binding activities in human skeletal muscle. FASEB J. 2006 Feb;20(2):348-9."
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;75;;MEF2 DNA binding;MEF2 DNA-binding activity;1;1;;0;;;;;cycling for 60 min at 75% of VO2peak;McGee 2005;"Sean L. McGee. David Sparling. Ann-Louise Olson. and Mark Hargreaves. Exercise increases MEF2- and GEF DNA-binding activities in human skeletal muscle. FASEB J. 2006 Feb;20(2):348-9."
Homo sapiens;1;sedentary;47;vastus lateralis;;Endurance;3600;60;75;;GEF nuclear;nuclear abundance of GEF;1;1;;0;;;;;cycling for 60 min at 75% of VO2peak;McGee 2005;"Sean L. McGee. David Sparling. Ann-Louise Olson. and Mark Hargreaves. Exercise increases MEF2- and GEF DNA-binding activities in human skeletal muscle. FASEB J. 2006 Feb;20(2):348-9."
Homo sapiens;1;active;47;vastus lateralis;I;All-Out;10;0.17;300;;ATP;;0;1;;0;;;;;maximum power output tests 10 and 25 sec pedalling at 120 revs/min;Sargeant 2006;A.J. Sargeant. A. De Haan. Human Muscle Fatigue: The Significance Of Muscle Fibre Type Variability Studied Using A Micro-Dissection Approach. Journal Of Physiology And Pharmacology 2006. 57. Suppl 10. 5-16.
Homo sapiens;1;active;47;vastus lateralis;IIa;All-Out;10;0.17;300;;ATP;;0;0.6;;0;;;;;maximum power output tests 10 and 25 sec pedalling at 120 revs/min;Sargeant 2006;A.J. Sargeant. A. De Haan. Human Muscle Fatigue: The Significance Of Muscle Fibre Type Variability Studied Using A Micro-Dissection Approach. Journal Of Physiology And Pharmacology 2006. 57. Suppl 10. 5-16.
Homo sapiens;1;active;47;vastus lateralis;IIx;All-Out;10;0.17;300;;ATP;;0;0.3;;0;;;;;maximum power output tests 10 and 25 sec pedalling at 120 revs/min;Sargeant 2006;A.J. Sargeant. A. De Haan. Human Muscle Fatigue: The Significance Of Muscle Fibre Type Variability Studied Using A Micro-Dissection Approach. Journal Of Physiology And Pharmacology 2006. 57. Suppl 10. 5-16.
Homo sapiens;1;active;47;vastus lateralis;I;All-Out;25;0.42;300;;ATP;;0;0.8;;0;;;;;maximum power output tests 10 and 25 sec pedalling at 120 revs/min;Sargeant 2006;A.J. Sargeant. A. De Haan. Human Muscle Fatigue: The Significance Of Muscle Fibre Type Variability Studied Using A Micro-Dissection Approach. Journal Of Physiology And Pharmacology 2006. 57. Suppl 10. 5-16.
Homo sapiens;1;active;47;vastus lateralis;IIa;All-Out;25;0.42;300;;ATP;;0;0.4;;0;;;;;maximum power output tests 10 and 25 sec pedalling at 120 revs/min;Sargeant 2006;A.J. Sargeant. A. De Haan. Human Muscle Fatigue: The Significance Of Muscle Fibre Type Variability Studied Using A Micro-Dissection Approach. Journal Of Physiology And Pharmacology 2006. 57. Suppl 10. 5-16.
Homo sapiens;1;active;47;vastus lateralis;IIx;All-Out;25;0.42;300;;ATP;;0;0.25;;0;;;;;maximum power output tests 10 and 25 sec pedalling at 120 revs/min;Sargeant 2006;A.J. Sargeant. A. De Haan. Human Muscle Fatigue: The Significance Of Muscle Fibre Type Variability Studied Using A Micro-Dissection Approach. Journal Of Physiology And Pharmacology 2006. 57. Suppl 10. 5-16.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;STAT3p-;STAT3 phosphorylation;1;5;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;STAT3p- nuclear;Phosphorylated STAT3 translocates to the nucleus;1;14;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;c-FOS mRNA;;1;800;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;JUNB mRNA;;1;38;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;VEGF mRNA;;1;4;;4;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;c-MYC mRNA;;1;140;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;IL-6 mRNA;;1;85;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;IL-6R mRNA;IL-6 receptor;1;8;;4;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;LIF;leukemia inhibitory factor;1;120;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;;vastus lateralis;;Strength;75;1.25;300;concentric;SOCS3;suppressor of cytokine signaling 3;1;60;;2;;;;;3 sets of 12 rep / 2 min between sets. max single-legged knee extension;Trenerry 2007;Trenerry MK. Carey KA. Ward AC. Cameron-Smith D. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J Appl Physiol 102: 1483?1489. 2007.
Homo sapiens;1;active;55;vastus lateralis;;Endurance;5400;90;50;;AMPKa2 activity;;1;1;;0;;;;;50% VO2max for 90 min;Wojtaszewski 2000;J?rgen F. P. Wojtaszewski. Pernille Nielsen. Bo F. Hansen*. Erik A. Richter and Bente Kiens. Isoform-specific and exercise intensity-dependent activation of 5?-AMP-activated protein kinase in human skeletal muscle. Journal of Physiology (2000). 528.1. pp. 221?226.
Homo sapiens;1;active;55;vastus lateralis;;Endurance;3600;60;75;;AMPKa2 activity;;1;43588;;0;;;;;75% VO2max for 60 min;Wojtaszewski 2000;J?rgen F. P. Wojtaszewski. Pernille Nielsen. Bo F. Hansen*. Erik A. Richter and Bente Kiens. Isoform-specific and exercise intensity-dependent activation of 5?-AMP-activated protein kinase in human skeletal muscle. Journal of Physiology (2000). 528.1. pp. 221?226.
Homo sapiens;1;active;55;vastus lateralis;;Endurance;5400;90;50;;AMPKa1 activity;;1;1;;0;;;;;50% VO2max for 90 min;Wojtaszewski 2000;J?rgen F. P. Wojtaszewski. Pernille Nielsen. Bo F. Hansen*. Erik A. Richter and Bente Kiens. Isoform-specific and exercise intensity-dependent activation of 5?-AMP-activated protein kinase in human skeletal muscle. Journal of Physiology (2000). 528.1. pp. 221?226.
Homo sapiens;1;active;55;vastus lateralis;;Endurance;3600;60;75;;AMPKa1 activity;;1;1;;0;;;;;75% VO2max for 60 min;Wojtaszewski 2000;J?rgen F. P. Wojtaszewski. Pernille Nielsen. Bo F. Hansen*. Erik A. Richter and Bente Kiens. Isoform-specific and exercise intensity-dependent activation of 5?-AMP-activated protein kinase in human skeletal muscle. Journal of Physiology (2000). 528.1. pp. 221?226.
Homo sapiens;1;active;55;vastus lateralis;;Endurance;5400;90;50;;muscle glycogen;;0;0.692640692640693;;0;462;320;;;50% VO2max for 90 min;Wojtaszewski 2000;J?rgen F. P. Wojtaszewski. Pernille Nielsen. Bo F. Hansen*. Erik A. Richter and Bente Kiens. Isoform-specific and exercise intensity-dependent activation of 5?-AMP-activated protein kinase in human skeletal muscle. Journal of Physiology (2000). 528.1. pp. 221?226.
Homo sapiens;1;active;55;vastus lateralis;;Endurance;3600;60;75;;muscle glycogen;;0;0.537735849056604;;0;530;285;;;75% VO2max for 60 min;Wojtaszewski 2000;J?rgen F. P. Wojtaszewski. Pernille Nielsen. Bo F. Hansen*. Erik A. Richter and Bente Kiens. Isoform-specific and exercise intensity-dependent activation of 5?-AMP-activated protein kinase in human skeletal muscle. Journal of Physiology (2000). 528.1. pp. 221?226.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;AMPKp-;phosphorylation of a-AMPK (Thr172);1;19419;;0;;;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;AMPKp-;phosphorylation of a-AMPK (Thr172);1;13881;;0;;;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;ACCp-;Acetyl CoA-carboxylase b-phosphorylation (Ser221);1;11;;0;;;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;ACCp-;Acetyl CoA-carboxylase b-phosphorylation (Ser221);1;43589;;0;;;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;La blood ;;1;9.125;;0;0.8;43531;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;La blood ;;1;8;;0;0.8;43561;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;epinephrine;Plasma epinephrine. nM;1;27638;;0;0.4;43711;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;epinephrine;Plasma epinephrine. nM;1;7.16666666666667;;0;0.6;43528;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;norepinephrine;Plasma norepinephrine. nM;1;1817327;;0;43617;43600;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;norepinephrine;Plasma norepinephrine. nM;1;12.1666666666667;;0;43678;43729;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;La muscle;Muscle lactate. mmol/kg dry wt;1;8.21917808219178;;0;43531;60;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;La muscle;Muscle lactate. mmol/kg dry wt;1;10;;0;43469;41;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;Cr;Creatine. mmol/kg dry wt;1;2.44186046511628;;0;43;105;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;Cr;Creatine. mmol/kg dry wt;1;1.7906976744186;;0;43;77;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;PCr;PCr. mmol/kg dry wt;0;0.32183908045977;;0;87;28;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;PCr;PCr. mmol/kg dry wt;0;0.643835616438356;;0;73;47;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;PCr/(PCr + Cr);;0;0.603174603174603;;0;0.63;0.38;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;PCr/(PCr + Cr);;0;0.313432835820895;;0;0.67;0.21;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;ATP;ATP. mmol/kg dry wt;0;0.991869918699187;;0;43640;43579;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;ATP;ATP. mmol/kg dry wt;0;0.934108527131783;;0;43702;43489;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;ADP;ADP. mmol/kg dry wt;1;1.09771986970684;;0;43649;13575;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;ADP;ADP. mmol/kg dry wt;1;1.14202898550725;;0;16497;34394;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;AMP;AMP. mmol/kg dry wt;0;0.880952380952381;;0;0.42;0.37;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;AMP;AMP. mmol/kg dry wt;0;0.864864864864865;;0;0.37;0.32;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;IMP;IMP. mmol/kg dry wt;0;22.6666666666667;;0;0.03;0.68;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;IMP;IMP. mmol/kg dry wt;0;8.625;;0;0.08;0.69;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;AMPfree;AMPfree. mkmol/kg dry wt;0;2273668;;0;0.96;43648;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;AMPfree;AMPfree. mkmol/kg dry wt;0;15.2333333333333;;0;0.6;41883;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;AMPfree/ATP;AMPfree/ATP. (X1.000);0;27426;;0;0.04;0.11;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;AMPfree/ATP;AMPfree/ATP. (X1.000);0;43603;;0;0.02;0.37;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;muscle glycogen;mmol/kg dry wt;0;0.637931034482759;;0;580;370;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;muscle glycogen;mmol/kg dry wt;0;0.636363636363636;;0;440;280;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;AMPKa2 activity;;0;43466;;0;;;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;AMPKa2 activity;;0;30682;;0;;;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;trained;66;vastus lateralis;;Endurance;1200;20;80;;AMPKa1 activity;;0;43525;;0;2;43618;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1200;20;80;;AMPKa1 activity;;0;1.31034482758621;;0;16438;43709;;;20  min of cycle exercise at 80% of peak O2 uptake;Nielsen 2003;Nielsen. Jakob N.. Kirsty J. W. Mustard. Drew A. Graham. Haiyan Yu. Christopher S. MacDonald. Henriette Pilegaard. Laurie J. Goodyear. D. Grahame Hardie. Erik A. Richter. and J?rgen F. P. Wojtaszewski. 5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J Appl Physiol 94: 631?641. 2003.
Homo sapiens;;sedentary;47;vastus lateralis;;Endurance;3600;60;63;;AMPKa1 activity;;1;45658;;0;;;;;60 min of cycling at 63% VO2peak;Lee-Young 2008;Lee-Young. R. S.. G. Koufogiannis. B. J. Canny. and G. K. McConell. Acute Exercise Does Not Cause Sustained Elevations in AMPK Signaling or Expression. Med. Sci. Sports Exerc.. Vol. 40. No. 8. pp. 1490?1494. 2008.
Homo sapiens;;sedentary;47;vastus lateralis;;Endurance;3600;60;63;;AMPKa2 activity;;1;43619;;0;;;;;60 min of cycling at 63% VO2peak;Lee-Young 2008;Lee-Young. R. S.. G. Koufogiannis. B. J. Canny. and G. K. McConell. Acute Exercise Does Not Cause Sustained Elevations in AMPK Signaling or Expression. Med. Sci. Sports Exerc.. Vol. 40. No. 8. pp. 1490?1494. 2008.
Homo sapiens;;sedentary;47;vastus lateralis;;Endurance;3600;60;63;;AMPKp-;AMPKa2 Thr172 phosphorylation;1;43587;;0;;;;;60 min of cycling at 63% VO2peak;Lee-Young 2008;Lee-Young. R. S.. G. Koufogiannis. B. J. Canny. and G. K. McConell. Acute Exercise Does Not Cause Sustained Elevations in AMPK Signaling or Expression. Med. Sci. Sports Exerc.. Vol. 40. No. 8. pp. 1490?1494. 2008.
Homo sapiens;;sedentary;47;vastus lateralis;;Endurance;3600;60;63;;ACCp-;ACC-b Ser222 phosphorylation;1;7;;0;;;;;60 min of cycling at 63% VO2peak;Lee-Young 2008;Lee-Young. R. S.. G. Koufogiannis. B. J. Canny. and G. K. McConell. Acute Exercise Does Not Cause Sustained Elevations in AMPK Signaling or Expression. Med. Sci. Sports Exerc.. Vol. 40. No. 8. pp. 1490?1494. 2008.
Homo sapiens;;sedentary;47;vastus lateralis;;Endurance;3600;60;63;;nNOSp-;nNOSm Ser1451 phosphorylation;1;43498;;0;;;;;60 min of cycling at 63% VO2peak;Lee-Young 2008;Lee-Young. R. S.. G. Koufogiannis. B. J. Canny. and G. K. McConell. Acute Exercise Does Not Cause Sustained Elevations in AMPK Signaling or Expression. Med. Sci. Sports Exerc.. Vol. 40. No. 8. pp. 1490?1494. 2008.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;ATP;;0;0.6;;0;30;18;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;PCr;;0;0.268292682926829;;0;82;22;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;Cr;;1;2.13207547169811;;0;53;113;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;PCr/(PCr + Cr);calculated by me;1;0.268292682926829;;0;0,61;0,16;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;La muscle;;1;6.93333333333333;;0;15;104;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;muscle glycogen;;0;0.696055684454756;;0;431;300;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;p38 MAPKp-;;1;12055;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;CaMKIIp-;;1;42736;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;PGC-1a mRNA;;1;3;;3;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;AMPKp-;;1;13516;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;AMPKa1p-;;1;46023;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;AMPKa2p-;;1;26665;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;ACCp-;;1;10;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;47;vastus lateralis;;All-Out;120;2;300;;PKBp-;;0;0.5;;0;;;;;4 X 30-s ?all out? / 4 min of rest;Gibala 2009;Gibala MJ. McGee SL. Garnham AP. Howlett KF. Snow RJ. Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1a in human skeletal muscle. J Appl Physiol 106: 929?934. 2009.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;ATP;ATP. mmol/kg;0;0.478346456692913;;0;43682;15738;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;ATP;ATP. mmol/kg;0;0.707661290322581;;0;35156;18688;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;AMP/ATP;AMP/ATP. mmol/mol;1;21.6075949367089;;0;43715;170.7;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;AMP/ATP;AMP/ATP. mmol/mol;1;16.0714285714286;;0;43500;67.5;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;PCr;Phosphocreatine. mmol/kg;0;0.309956167814652;;0;15.97;34790;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;PCr;Phosphocreatine. mmol/kg;0;0.339898705683737;;0;17.77;43561;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;Cr;Creatine. mmol/kg;1;1.88585209003215;;0;16407;23.46;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;Cr;Creatine. mmol/kg;1;2.10244360902256;;0;23651;22.37;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;PCr/(PCr + Cr);calculated by me;0;0.309956167814653;;0;#????!;#????!;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;PCr/(PCr + Cr);calculated by me;0;0.339898705683737;;0;#????!;#????!;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;Pyr muscle;Pyr. mmol/kg;1;3.11111111111111;;0;0.09;0.28;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;Pyr muscle;Pyr. mmol/kg;1;43679;;0;0.1;0.28;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;La muscle;Lac. mmol/kg;1;14.8076923076923;;0;43618;38.5;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;La muscle;Lac. mmol/kg;1;43510;;0;43587;35.5;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;Lac/Pyr muscle;;1;4.82724252491694;;0;43495;145.3;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;Lac/Pyr muscle;;1;3.46133333333333;;0;37.5;129.8;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;NAD+/NADH.H+;[NAD+]/([NADH.H+]). X 10-7;0;0.145426287744227;;0;450.4;65.5;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;NAD+/NADH.H+;[NAD+]/([NADH.H+]). X 10-7;0;0.177003624647604;;0;496.6;87.9;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;AMPKp-;Thr172-AMPKa phosphorylation;1;43499;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;AMPKp-;Thr172-AMPKa phosphorylation;1;1;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;ACCp-;Ser221-ACCb phosphorylation;1;43711;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;ACCp-;Ser221-ACCb phosphorylation;1;43558;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;CaMKIIp-;Thr286-CaMKII phosphorylation;1;19360;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;CaMKIIp-;Thr286-CaMKII phosphorylation;1;1;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;Aktp-;Ser473-Akt phosphorylation;1;43709;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;Aktp-;Ser473-Akt phosphorylation;1;43557;;30;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;;Ser485-AMPKa1p-;Ser485-AMPKa1/Ser491-AMPKa2 phosphorylation;1;1;;0;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;All-Out;30;0.5;300;Antioxidants;Ser485-AMPKa1p-;Ser485-AMPKa1/Ser491-AMPKa2 phosphorylation;1;20821;;0;;;;;30-s sprint (Wingate test);Morales-Alamo 2013;Morales-Alamo D. Ponce-Gonz?lez JG. Guadalupe-Grau A. Rodr?guez-Garc?a L. Santana A. Cusso R. Guerrero M. Dorado C. Guerra B. Calbet JA. Critical role for free radicals on sprint exercise-induced CaMKII and AMPKa phosphorylation in human skeletal muscle. J Appl Physiol 114: 566?577. 2013.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;Glucose blood;;;1;;;43712;43712;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;Glucose blood;;;1;;;43712;43712;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;Glucose blood;;;0.673469387755102;;;43712;43527;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;La blood ;;;43527;;;0.6;35796;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;AMPKa1 activity;;;1;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;AMPKa1 activity;;;43466;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;AMPKa1 activity;;;43497;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;AMPKa2 activity;;;43617;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;AMPKa2 activity;;;43647;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;AMPKa2 activity;;;43587;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;AMPKp-;Thr172-AMPKa phosphorylation;;43556;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;AMPKp-;Thr172-AMPKa phosphorylation;;43586;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;AMPKp-;Thr172-AMPKa phosphorylation;;43678;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;ACCp-;ACCb Ser221 phoshorylation;;43681;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;ACCp-;ACCb Ser221 phoshorylation;;3;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;ACCp-;ACCb Ser221 phoshorylation;;43587;;;;;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;ATP;ATP (mmol/kg d.w.);;1.05737704918033;;;43579;43702;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;ATP;ATP (mmol/kg d.w.);;1.06967213114754;;;43579;43491;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;ATP;ATP (mmol/kg d.w.);;1.05737704918033;;;43579;43702;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;ADP;ADP (mmol/kg d.w.);;1.07407407407407;;;43648;43710;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;ADP;ADP (mmol/kg d.w.);;1.07407407407407;;;43648;43710;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;ADP;ADP (mmol/kg d.w.);;1.07407407407407;;;43648;43710;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;AMP;AMP (mmol/kg d.w.);;43466;;;0.1;0.11;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;AMP;AMP (mmol/kg d.w.);;43497;;;0.1;0.12;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;AMP;AMP (mmol/kg d.w.);;43466;;;0.1;0.11;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;AMP/ATP;AMP/ATP (%);;1;;;0.43;0.43;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;AMP/ATP;AMP/ATP (%);;1.06976744186047;;;0.43;0.46;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;AMP/ATP;AMP/ATP (%);;1;;;0.43;0.43;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;PCr;PCr (mmol/kg d.w.);;0.779237844940867;;;76.1;59.3;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;PCr;PCr (mmol/kg d.w.);;0.816031537450723;;;76.1;62.1;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;PCr;PCr (mmol/kg d.w.);;0.9526938239159;;;76.1;72.5;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;Cr;Cr (mmol/kg d.w.);;1.53626943005181;;;38.6;59.3;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;Cr;Cr (mmol/kg d.w.);;1.59326424870466;;;38.6;61.5;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;Cr;Cr (mmol/kg d.w.);;1.47668393782383;;;38.6;57;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;3600;60;44;;PCr/(PCr + Cr);PCr/(PCr+Cr) (%);;0.75867269984917;;;0.663;0.503;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;44;;PCr/(PCr + Cr);PCr/(PCr+Cr) (%);;0.75867269984917;;;0.663;0.503;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;12480;208;44;;PCr/(PCr + Cr);PCr/(PCr+Cr) (%);;0.846153846153846;;;0.663;0.561;;;low intensity cycling exercise was performed until exhaustion;Wojtaszewski 2002;J?rgen F.P. Wojtaszewski. Marina Mourtzakis. Thore Hillig. Bengt Saltin. and Henriette Pilegaard. Dissociation of AMPK activity and ACCb phosphorylation in human muscle during prolonged exercise. Biochemical andBiophysical Research Communications 298 (2002) 309?316.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;La plasma ;Lactate (mmol/l);;1.45454545454545;;;43466;43617;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;La plasma ;Lactate (mmol/l);;2.54545454545454;;;43466;43679;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;La plasma ;Lactate (mmol/l);;6.54545454545454;;;43466;43503;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;La muscle;Lactate (mmol/kg dry wt);;1.75862068965517;;;43710;43470;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;La muscle;Lactate (mmol/kg dry wt);;4.62068965517241;;;43710;43568;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;La muscle;Lactate (mmol/kg dry wt);;6.79310344827586;;;43710;43665;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;ATP;ATP (mmol/kg dry wt);;1.00446428571429;;;43577;43607;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;ATP;ATP (mmol/kg dry wt);;1;;;43577;43577;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;ATP;ATP (mmol/kg dry wt);;0.919642857142857;;;43577;43636;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;ADPfree ;Free ADP (mkmol/kg dry wt);;1.31864095500459;;;108.9;143.6;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;ADPfree ;Free ADP (mkmol/kg dry wt);;2.73921028466483;;;108.9;298.3;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;ADPfree ;Free ADP (mkmol/kg dry wt);;5.82644628099174;;;108.9;634.5;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;AMPfree ;Free AMP (mkmol/kg dry wt);;1.66666666666667;;;0.6;1;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;AMPfree ;Free AMP (mkmol/kg dry wt);;9.66666666666667;;;0.6;43682;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;AMPfree ;Free AMP (mkmol/kg dry wt);;46.1666666666667;;;0.6;43673;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;AMPfree/ATP;Free AMP/ATP ratio;;1.33333333333333;;;0.03;0.04;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;AMPfree/ATP;Free AMP/ATP ratio;;7.33333333333333;;;0.03;0.22;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;AMPfree/ATP;Free AMP/ATP ratio;;36.6666666666667;;;0.03;43466;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;PCr;Creatine phosphate (mmol/kg dry wt);;0.911082474226804;;;77.6;70.7;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;PCr;Creatine phosphate (mmol/kg dry wt);;0.675257731958763;;;77.6;52.4;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;PCr;Creatine phosphate (mmol/kg dry wt);;0.457474226804124;;;77.6;35.5;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;Cr;Creatine (mmol/kg dry wt);;1.1869918699187;;;36.9;43.8;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;Cr;Creatine (mmol/kg dry wt);;1.80216802168022;;;36.9;66.5;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;Cr;Creatine (mmol/kg dry wt);;2.22222222222222;;;36.9;82;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;PCr/(PCr + Cr);calculated by me;;0.911082474226804;;;0.677729257641921;0.617467248908297;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;PCr/(PCr + Cr);calculated by me;;0.650269220431273;;;0.677729257641921;0.440706476030278;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;PCr/(PCr + Cr);calculated by me;;0.445794033779338;;;0.677729257641921;0.302127659574468;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;AMPK activity;AMPK kinase activity;;43466;;;;;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;AMPK activity;AMPK kinase activity;;43617;;;;;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;AMPK activity;AMPK kinase activity;;43647;;;;;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;AMPKa1 activity;;;43466;;;;;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;AMPKa1 activity;;;43617;;;;;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;AMPKa1 activity;;;43617;;;;;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;AMPKa2 activity;;;43497;;;;;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;AMPKa2 activity;;;5;;;;;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;AMPKa2 activity;;;8;;;;;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;ACCp-;ACCb Ser221 phoshorylation;;3;;;;;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;ACCp-;ACCb Ser221 phoshorylation;;8;;;;;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;ACCp-;ACCb Ser221 phoshorylation;;10;;;;;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;40;;nNOSp-;nNOSm phosphorylation;;43467;;;;;;;cycling 20 min at 40% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;59;;nNOSp-;nNOSm phosphorylation;;43499;;;;;;;cycling 20 min at 60% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;48;vastus lateralis;;Endurance;1200;20;79;;nNOSp-;nNOSm phosphorylation;;43528;;;;;;;cycling 20 min at 80% of VO2 peak;Chen 2003;Zhi-Ping Chen. Terry J. Stephens. Sid Murthy. Benedict J. Canny. Mark Hargreaves. Lee A. Witters. Bruce E. Kemp. and Glenn K. McConell. Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans. Diabetes 52:2205?2212. 2003.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1800;30;70;;AMPKp-;Thr172-AMPKa phosphorylation;;43466;;;;;;;;Combes 2015;Adrien Combes. Jeanne Dekerle. Nick Webborn. Peter Watt. Valerie Bougault & Frederic N. Daussin. Exercise-induced metabolic fluctuations influence AMPK. p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol Rep. 3 (9). 2015.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;3600;60;70;intermittent modality;AMPKp-;Thr172-AMPKa phosphorylation;;43710;;;;;;;The intermittent exercise was 30 x [1-min work / 1-min of recovery];Combes 2015;Adrien Combes. Jeanne Dekerle. Nick Webborn. Peter Watt. Valerie Bougault & Frederic N. Daussin. Exercise-induced metabolic fluctuations influence AMPK. p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol Rep. 3 (9). 2015.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1800;30;70;;p38 MAPKp-;p-p38 MAPK Thr180/Tyr182 phosphorylation;;43556;;;;;;;;Combes 2015;Adrien Combes. Jeanne Dekerle. Nick Webborn. Peter Watt. Valerie Bougault & Frederic N. Daussin. Exercise-induced metabolic fluctuations influence AMPK. p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol Rep. 3 (9). 2015.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;3600;60;70;intermittent modality;p38 MAPKp-;p-p38 MAPK Thr180/Tyr182 phosphorylation;;43500;;;;;;;The intermittent exercise was 30 x [1-min work / 1-min of recovery];Combes 2015;Adrien Combes. Jeanne Dekerle. Nick Webborn. Peter Watt. Valerie Bougault & Frederic N. Daussin. Exercise-induced metabolic fluctuations influence AMPK. p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol Rep. 3 (9). 2015.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;1800;30;70;;CaMKIIp-;Thr286-CaMKII phosphorylation;;43525;;;;;;;;Combes 2015;Adrien Combes. Jeanne Dekerle. Nick Webborn. Peter Watt. Valerie Bougault & Frederic N. Daussin. Exercise-induced metabolic fluctuations influence AMPK. p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol Rep. 3 (9). 2015.
Homo sapiens;1;sedentary;44;vastus lateralis;;Endurance;3600;60;70;intermittent modality;CaMKIIp-;Thr286-CaMKII phosphorylation;;43648;;;;;;;The intermittent exercise was 30 x [1-min work / 1-min of recovery];Combes 2015;Adrien Combes. Jeanne Dekerle. Nick Webborn. Peter Watt. Valerie Bougault & Frederic N. Daussin. Exercise-induced metabolic fluctuations influence AMPK. p38-MAPK and CaMKII phosphorylation in human skeletal muscle. Physiol Rep. 3 (9). 2015.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;;muscle glycogen;;;0.662824207492795;;;694;460;;;;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;high-fat diet;muscle glycogen;;;0.674588665447898;;;547;369;;;;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;;AMPKa1 activity;;;43556;;;;;;;60 min of cycling at 70% VO2max;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;high-fat diet;AMPKa1 activity;;;43497;;;;;;;60 min of cycling at 70% VO2max;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;;AMPKa2 activity;;;12785;;;;;;;60 min of cycling at 70% VO2max;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;high-fat diet;AMPKa2 activity;;;43497;;;;;;;60 min of cycling at 70% VO2max;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;;ACCp-;ACCb Ser221 phoshorylation;;43556;;;;;;;60 min of cycling at 70% VO2max;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;trained;61.5;vastus lateralis;;Endurance;3600;60;70;high-fat diet;ACCp-;ACCb Ser221 phoshorylation;;43556;;;;;;;60 min of cycling at 70% VO2max;Yeo 2008;Yeo WK. Lessard SJ. Chen ZP. Garnham AP. Burke LM. Rivas DA. Kemp BE. Hawley JA. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. J Appl Physiol 105: 1519?1526. 2008.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;Plasma insulin;Plasma insulin (microIU ml-1);;0.606299212598425;;;29646;11355;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;Plasma insulin;Plasma insulin (microIU ml-1);;1.90519187358916;;;15797;16285;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;La blood ;Blood lactate (mmol l-1);;6.57142857142857;;;0.7;43620;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;La blood ;Blood lactate (mmol l-1);;20;;;0.7;14;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;epinephrine;Adrenaline (nmol l-1);;43510;;;0.2;30713;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;epinephrine;Adrenaline (nmol l-1);;8.74193548387097;;;0.31;25965;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;norepinephrine;Noradrenaline (nmol l-1);;13.5949367088608;;;21186;21.48;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;norepinephrine;Noradrenaline (nmol l-1);;17.4619883040936;;;25934;29.86;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;muscle glycogen;Glycogen (nmol (mg protein)-1);;0.540362438220758;;;607;328;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;muscle glycogen;Glycogen (nmol (mg protein)-1);;0.418674698795181;;;664;278;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;La muscle;Lactate (mmol (kg dry wt)-1);;1.14709677419355;;;77.5;88.9;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;La muscle;Lactate (mmol (kg dry wt)-1);;2.20057306590258;;;69.8;153.6;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;Cr;Cr (mmol (kg dry wt)-1);;1.55821917808219;;;29.2;45.5;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;Cr;Cr (mmol (kg dry wt)-1);;2.38610038610039;;;43733;61.8;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;PCr;PCr (mmol (kg dry wt)-1);;0.83843537414966;;;58.8;49.3;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;PCr;PCr (mmol (kg dry wt)-1);;0.515806988352745;;;60.1;31;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;PCr/(PCr + Cr);PCr/(Cr + PCr) (x 100);;0.772861356932153;;;67.8;52.4;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;PCr/(PCr + Cr);PCr/(Cr + PCr) (x 100);;0.477825464949928;;;69.9;33.4;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;AMPKa1 activity;a1b2g1 AMPK activity;;0.855421686746988;;;24108;15342;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;AMPKa1 activity;a1b2g1 AMPK activity;;0.811688311688312;;;19725;45658;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;AMPKa2y1 activity;a2b2g1 AMPK activity;;1.15789473684211;;;0.95;43466;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;AMPKa2y1 activity;a2b2g1 AMPK activity;;43497;;;1;43497;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;AMPKa2y3 activity;a2b2g3 AMPK activity;;35034;;;0.2;21582;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;AMPKa2y3 activity;a2b2g3 AMPK activity;;43613;;;0.2;43651;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;AMPKp-;pAMPKThr172;;2.06741573033708;;;89;184;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;AMPKp-;pAMPKThr172;;2.48275862068966;;;87;216;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;ACCp-;pACCSer221;;6.42857142857143;;;49;315;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;ACCp-;pACCSer221;;8.71111111111111;;;45;392;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;TBC1D4p-;pTBC1D4Ser704;;1.82683982683983;;;231;422;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;TBC1D4p-;pTBC1D4Ser704;;2.72072072072072;;;222;604;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;TBC1D1p-;pTBC1D1Ser231;;1.42592592592593;;;216;308;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;TBC1D1p-;pTBC1D1Ser231;;1.87383177570093;;;214;401;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;GS2p-;pGS 2+2a;;3.39814814814815;;;108;367;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;GS2p-;pGS 2+2a;;2.23255813953488;;;129;288;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance;1800;30;69;;GS3p-;pGS 3a+3b;;0.585333333333333;;;750;439;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;;Endurance IT;540;9;95;;GS3p-;pGS 3a+3b;;0.41956241956242;;;777;326;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;muscle glycogen;Glycogen (nmol (mg protein)?1);;0.573770491803279;;;610;350;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;muscle glycogen;Glycogen (nmol (mg protein)?1);;0.45;;;800;360;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;muscle glycogen;Glycogen (nmol (mg protein)?1);;0.614035087719298;;;570;350;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;muscle glycogen;Glycogen (nmol (mg protein)?1);;0.253164556962025;;;790;200;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;AMPKp-;pAMPKThr172;;1.88888888888889;;;90;170;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;AMPKp-;pAMPKThr172;;45689;;;80;180;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;AMPKp-;pAMPKThr172;;43586;;;100;150;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;AMPKp-;pAMPKThr172;;3;;;80;240;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;ACCp-;pACCSer221;;43622;;;100;660;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;ACCp-;pACCSer221;;8.375;;;80;670;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;ACCp-;pACCSer221;;45870;;;80;660;;;30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;ACCp-;pACCSer221;;12.8333333333333;;;60;770;;;6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;TBC1D1p-;pTBC1D1Ser231;;43556;;;500;700;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;TBC1D1p-;pTBC1D1Ser231;;1.68421052631579;;;950;1600;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;TBC1D1p-;pTBC1D1Ser231;;1.625;;;400;650;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;TBC1D1p-;pTBC1D1Ser231;;2.06666666666667;;;750;1550;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;TBC1D4p-;pTBC1D4Ser704;;1.66666666666667;;;450;750;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;TBC1D4p-;pTBC1D4Ser704;;2.27272727272727;;;550;1250;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;TBC1D4p-;pTBC1D4Ser704;;1.85714285714286;;;350;650;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;TBC1D4p-;pTBC1D4Ser704;;3.57142857142857;;;350;1250;;;GTPase-activating proteins TBC1 domain family members (TBC1D) 1 and 4 regulating cellular transport of GLUT4-containing vesicles;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;GS2p-;pGS 2+2a;;1.76666666666667;;;300;530;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;GS2p-;pGS 2+2a;;1.30434782608696;;;230;300;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;GS2p-;pGS 2+2a;;2273637;;;320;580;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;GS2p-;pGS 2+2a;;1.13636363636364;;;220;250;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;GS3p-;pGS 3a+3b;;0.535714285714286;;;1400;750;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;GS3p-;pGS 3a+3b;;0.416666666666667;;;1200;500;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;I;Endurance;1800;30;69;;GS3p-;pGS 3a+3b;;0.5;;;1600;800;;;glycogen synthase (GS) 30 min of cycling at 70% VO2peak;Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;sedentary;50;vastus lateralis;II;Endurance IT;540;9;95;;GS3p-;pGS 3a+3b;;0.25;;;1400;350;;;glycogen synthase (GS) 6 x [1.5 min at 95 VO2peak / 2.5min at 40% VO2peak];Kristensen 2015;Dorte E. Kristensen. Peter H. Albers. Clara Prats. Otto Baba. Jesper B. Birk1 and J?rgen F. P. Wojtaszewski. Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise. J Physiol 0.0 (2015) pp 1?17 1.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;60;;AMPKp-;;;2;;;;;;;one-legged knee-extensor exercise at 60% of Wmax for 2 h;Akerstrom 2006;Thorbjorn C.A. Akerstrom. Jesper B. Birk. Ditte K. Klein. Christian Erikstrup. Peter Plomgaard. Bente Klarlund Pedersen. J?rgen F.P. Wojtaszewski. Oral glucose ingestion attenuates exercise-induced activation of 50-AMP-activated protein kinase in human skeletal muscle. Biochemical and Biophysical Research Communications 342 (2006) 949?955.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;60;oral glucose;AMPKp-;;;43648;;;;;;;one-legged knee-extensor exercise at 60% of Wmax for 2 h;Akerstrom 2006;Thorbjorn C.A. Akerstrom. Jesper B. Birk. Ditte K. Klein. Christian Erikstrup. Peter Plomgaard. Bente Klarlund Pedersen. J?rgen F.P. Wojtaszewski. Oral glucose ingestion attenuates exercise-induced activation of 50-AMP-activated protein kinase in human skeletal muscle. Biochemical and Biophysical Research Communications 342 (2006) 949?955.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;60;;AMPKa2 activity;;;1.71428571428571;;;0.14;0.24;;;one-legged knee-extensor exercise at 60% of Wmax for 2 h;Akerstrom 2006;Thorbjorn C.A. Akerstrom. Jesper B. Birk. Ditte K. Klein. Christian Erikstrup. Peter Plomgaard. Bente Klarlund Pedersen. J?rgen F.P. Wojtaszewski. Oral glucose ingestion attenuates exercise-induced activation of 50-AMP-activated protein kinase in human skeletal muscle. Biochemical and Biophysical Research Communications 342 (2006) 949?955.
Homo sapiens;1;active;50;vastus lateralis;;Endurance;7200;120;60;oral glucose;AMPKa2 activity;;;3.83333333333333;;;0.12;0.46;;;one-legged knee-extensor exercise at 60% of Wmax for 2 h;Akerstrom 2006;Thorbjorn C.A. Akerstrom. Jesper B. Birk. Ditte K. Klein. Christian Erikstrup. Peter Plomgaard. Bente Klarlund Pedersen. J?rgen F.P. Wojtaszewski. Oral glucose ingestion attenuates exercise-induced activation of 50-AMP-activated protein kinase in human skeletal muscle. Biochemical and Biophysical Research Communications 342 (2006) 949?955.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPKp-;Thr-172 ?-AMPK phosphorylation;;43587;;;;;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPKp-;Thr-172 ?-AMPK phosphorylation;;43586;;;;;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPKp-;Thr-172 ?-AMPK phosphorylation;;0.95;;;;;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPKa1 activity;;;1.27272727272727;;;;;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPKa1 activity;;;0.6;;;;;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPKa1 activity;;;0.65;;;;;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPKa2 activity;;;43588;;;;;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPKa2 activity;;;43586;;;;;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPKa2 activity;;;1;;;;;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPKb2 activity;;;43678;;;;;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPKb2 activity;;;0.9;;;;;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPKb2 activity;;;0.65;;;;;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPKa2y1 activity;?2?2?1 AMPK activity;;43497;;;;;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPKa2y1 activity;?2?2?1 AMPK activity;;0.8;;;;;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPKa2y1 activity;?2?2?1 AMPK activity;;0.6;;;;;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPKa2y3 activity;?2?2?3 AMPK activity;;18;;;;;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPKa2y3 activity;?2?2?3 AMPK activity;;6;;;;;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPKa2y3 activity;?2?2?3 AMPK activity;;5;;;;;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;La muscle;Lactate. mmol (kg dry weight)?1;;43500;;;5;21;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;La muscle;Lactate. mmol (kg dry weight)?1;;43513;;;5;86;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;La muscle;Lactate. mmol (kg dry weight)?1;;43694;;;5;89;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;Cr;Cr. mmol (kg dry weight)?1;;1.44186046511628;;;43;62;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;Cr;Cr. mmol (kg dry weight)?1;;1.86440677966102;;;59;110;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;Cr;Cr. mmol (kg dry weight)?1;;2.14583333333333;;;48;103;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;PCr;PCr. mmol (kg dry weight)?1;;0.938271604938272;;;81;76;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;PCr;PCr. mmol (kg dry weight)?1;;0.4;;;90;36;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;PCr;PCr. mmol (kg dry weight)?1;;0.506172839506173;;;81;41;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;PCr/(PCr + Cr);PCr/(Cr + PCr)(? 100);;0.848484848484849;;;66;56;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;PCr/(PCr + Cr);PCr/(Cr + PCr)(? 100);;0.39344262295082;;;61;24;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;PCr/(PCr + Cr);PCr/(Cr + PCr)(? 100);;0.46031746031746;;;63;29;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;ATP;ATP. mmol (kg dry weight)?1;;1;;;26;26;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;ATP;ATP. mmol (kg dry weight)?1;;0.769230769230769;;;26;20;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;ATP;ATP. mmol (kg dry weight)?1;;0.84;;;25;21;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPfree;AMPfree. ?mol (kg dry weight)?1;;2.14285714285714;;;0.7;43586;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPfree;AMPfree. ?mol (kg dry weight)?1;;2.36363636363636;;;43466;43618;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPfree;AMPfree. ?mol (kg dry weight)?1;;27395;;;0.8;43556;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;AMPfree/ATP;AMPfree/ATP (?1000);;2.59259259259259;;;27;70;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;AMPfree/ATP;AMPfree/ATP (?1000);;3.14634146341463;;;41;129;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;AMPfree/ATP;AMPfree/ATP (?1000);;1.875;;;32;60;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;Endurance;1200;20;77;;muscle glycogen;Glycogen. mmol (kg dry weight)?1;;0.621145374449339;;;454;282;;;20 min of bicycling at 80% VO2peak (77?3%);Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;HIT;120;2;110;;muscle glycogen;Glycogen. mmol (kg dry weight)?1;;0.8;;;425;340;;;120s at 110% of peak work rate;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;sedentary;52;vastus lateralis;;All-Out;30;0.5;300;;muscle glycogen;Glycogen. mmol (kg dry weight)?1;;0.802752293577982;;;436;350;;;30s sprint;Birk 2006;J. B. Birk and J. F. P.Wojtaszewski. Predominant ?2/?2/?3 AMPK activation during exercise in human skeletal muscle. J Physiol 577.3 (2006) pp 1021?1032 1021.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;ATP;ATP. mmol (kg dry weight)?1;;0.972602739726028;;;43729;43545;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;ATP;ATP. mmol (kg dry weight)?1;;1.01369863013699;;;43729;43518;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;ATP;ATP. mmol (kg dry weight)?1;;1.04901960784314;;;43575;43576;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;ATP;ATP. mmol (kg dry weight)?1;;0.985294117647059;;;43575;43485;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;ADP;ADP. mmol (kg dry weight)?1;;1.02857142857143;;;43588;43619;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;ADP;ADP. mmol (kg dry weight)?1;;0.942857142857143;;;43588;43527;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;ADP;ADP. mmol (kg dry weight)?1;;1.03225806451613;;;43468;43499;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;ADP;ADP. mmol (kg dry weight)?1;;0.967741935483871;;;43468;3;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;AMP;AMP. mmol/kg dry wt;;1.03846153846154;;;0.26;0.27;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMP;AMP. mmol/kg dry wt;;1.07692307692308;;;0.26;0.28;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;AMP;AMP. mmol/kg dry wt;;1.08695652173913;;;0.23;0.25;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;AMP;AMP. mmol/kg dry wt;;1;;;0.23;0.23;;;;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;AMP/ATP;AMP/ATP.%;;1.06666666666667;;;43497;46753;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMP/ATP;AMP/ATP.%;;1.03333333333333;;;43497;45292;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;AMP/ATP;AMP/ATP.%;;1.07272727272727;;;43466;43101;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;AMP/ATP;AMP/ATP.%;;1.02727272727273;;;43466;41275;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;Cr;Cr. mmol (kg dry weight)?1;;1.04734848484848;;;52.8;55.3;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;Cr;Cr. mmol (kg dry weight)?1;;1.06628787878788;;;52.8;56.3;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;Cr;Cr. mmol (kg dry weight)?1;;1.03212851405622;;;49.8;51.4;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;Cr;Cr. mmol (kg dry weight)?1;;1.00602409638554;;;49.8;50.1;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;PCr;PCr. mmol (kg dry weight)?1;;0.986357435197817;;;73.3;72.3;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;PCr;PCr. mmol (kg dry weight)?1;;1.12551159618008;;;73.3;82.5;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;PCr;PCr. mmol (kg dry weight)?1;;1.03133514986376;;;73.4;75.7;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;PCr;PCr. mmol (kg dry weight)?1;;1.03678474114441;;;73.4;76.1;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;PCr/(PCr + Cr);CrP/Crtotal.%;;0.948275862068966;;;58;55;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;PCr/(PCr + Cr);CrP/Crtotal.%;;1.03448275862069;;;58;60;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;PCr/(PCr + Cr);CrP/Crtotal.%;;1;;;60;60;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;PCr/(PCr + Cr);CrP/Crtotal.%;;1;;;60;60;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;epinephrine;epinephrine mkM;;27426;;;0.8;43498;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;epinephrine;epinephrine mkM;;6;;;0.8;43681;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;epinephrine;epinephrine mkM;;1.71428571428571;;;0.7;43497;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;epinephrine;epinephrine mkM;;1.71428571428571;;;0.7;43497;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;norepinephrine;norepinephrine mkM;;12;;;0.9;43687;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;norepinephrine;norepinephrine mkM;;16.8888888888889;;;0.9;43511;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;norepinephrine;norepinephrine mkM;;7.45454545454545;;;43466;43504;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;norepinephrine;norepinephrine mkM;;11.1818181818182;;;43466;43536;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;Insulin;Insulin. U/ml;;0.519480519480519;;;43653;4;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;Insulin;Insulin. U/ml;;0.363636363636364;;;43653;43679;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;Insulin;Insulin. U/ml;;0.638888888888889;;;43503;43620;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;Insulin;Insulin. U/ml;;0.541666666666667;;;43503;43711;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;AMPKa1 activity;;;0.936170212765957;;;43650;43559;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMPKa1 activity;;;0.797872340425532;;;43650;27454;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;AMPKa1 activity;;;1.03448275862069;;;43710;3;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;AMPKa1 activity;;;1.17241379310345;;;43710;43558;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;AMPKa2 activity;;;43586;;;43617;43557;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;AMPKa2 activity;;;1.625;;;43617;43618;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;AMPKa2 activity;;;1.27272727272727;;;43466;43556;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;AMPKa2 activity;;;1.36363636363636;;;43466;43586;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;Low glycogen;ACCp-;;;3.22222222222222;;;4500;14500;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;Low glycogen;ACCp-;;;3.22222222222222;;;4500;14500;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;600;10;70;High glycogen;ACCp-;;;2.51515151515152;;;3300;8300;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
Homo sapiens;1;well-trained;65;vastus lateralis;;Endurance;3600;60;70;High glycogen;ACCp-;;;2.87878787878788;;;3300;9500;;;cycling exercise for 1 h at 70% VO2peak;Wojtaszewski 2003;Wojtaszewski. J?rgen F. P.. Christopher MacDonald. Jakob N. Nielsen. Ylva Hellsten. D. Grahame Hardie. Bruce E. Kemp. Bente Kiens. and Erik A. Richter. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284: E813?E822. 2003.
